Analyses | Innovation and technology development | 2019-05-09 | HKET

Synthetic biology series (1): A technology that even the richest person in the city pours money into



Hong Kong tycoon Li Ka-shing is optimistic about the potential of synthetic biology, once described it as an ‘extremely disruptive technology’. Li’s investment arm Horizons Ventures has already invested in several synthetic biology startups in recent years, while foreign venture capital community also keeps an eye on it. What is synthetic biology? What are the potential impacts and risks?

The full version of the commentary is in Chinese only.